Li L - Search Results

1

Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era.

Zhang T, Tian W, Wei S, Lu X, An J, He S, Zhao J, Gao Z, Li L, Lian K, Zhou Q, Zhang H, Wang L, Su L, Kang H, Niu T, Zhao A, Pan J, Cai Q, Xu Z, Chen W, Jing H, Li P, Zhao W, Cao Y, Mi J, Chen T, Chen Y, Zou P, Lukacs-Kornek V, Kurts C, Li J, Liu X, Mei Q, Zhang Y, Wei J. Zhang T, et al. Among authors: li j, li l, li p. Exp Hematol Oncol. 2023 Jul 27;12(1):66. doi: 10.1186/s40164-023-00426-x. Exp Hematol Oncol. 2023. PMID: 37501090 Free PMC article. Review.

2

Different kinetic patterns of BCR-ABL transcript levels in imatinib-treated chronic myeloid leukemia patients after achieving complete cytogenetic response.

Qin YZ, Liu YR, Zhu HH, Li JL, Ruan GR, Zhang Y, Jiang Q, Jiang H, Li LD, Chang Y, Huang XJ, Chen SS. Qin YZ, et al. Among authors: li jl, li ld. Int J Lab Hematol. 2008 Aug;30(4):317-23. doi: 10.1111/j.1751-553X.2007.00962.x. Int J Lab Hematol. 2008. PMID: 18665830

3

[An interlaboratory comparison study on the detection of RUNX1-RUNX1T1 fusion transcript levels and WT1 transcript levels].

Qin YZ, Zhu LW, Lin S, Geng SX, Liu SW, Cheng H, Wu CY, Xiao M, Li XQ, Hu RP, Wang LL, Liu HY, Ma DX, Guan T, Ye YX, Niu T, Cen JN, Lu LS, Sun L, Yang TH, Wang YG, Li T, Wang Y, Li QH, Zhao XS, Li LD, Chen WM, Long LY, Huang XJ. Qin YZ, et al. Among authors: li t, li qh, li ld, li xq. Zhonghua Xue Ye Xue Za Zhi. 2019 Nov 14;40(11):889-894. doi: 10.3760/cma.j.issn.0253-2727.2019.11.001. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31856435 Free PMC article. Chinese.

4

[A three-series case report and literature review of acute myeloid leukemia with t(7;11)(p15;p15)/NUP98-HOXA9].

Zhang ZH, Wan W, Li LD, Dong F, Li QH, Wang YF, Wan WL, Wang H, Wang J, Jing HM. Zhang ZH, et al. Among authors: li qh, li ld. Zhonghua Xue Ye Xue Za Zhi. 2022 Feb 14;43(2):150-153. doi: 10.3760/cma.j.issn.0253-2727.2022.02.011. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 35381677 Free PMC article. Review. Chinese. No abstract available.

5

A tetraploid minimally differentiated acute myeloblastic leukemia with extensive erythrophagocytosis: a case report and literature review.

Li L, Li J, Li G, Tan Y, Chen X, Ren F, Guo H, Wang H. Li L, et al. Among authors: li j, li g. Int J Hematol. 2012 Dec;96(6):801-5. doi: 10.1007/s12185-012-1179-6. Epub 2012 Sep 28. Int J Hematol. 2012. PMID: 23054644 Review.

6

[Clinical, molecular and cytogenetic characteristics of newly diagnosed adult acute myeloid patients with TP53 gene mutation].

Chen WM, Liu H, Li LD, Long LY, Lai YY, Shi HX, Zhao XS, Jiang H, Jiang Q, Liu YR, Qin YZ. Chen WM, et al. Among authors: li ld. Zhonghua Xue Ye Xue Za Zhi. 2019 Jun 14;40(6):528-531. doi: 10.3760/cma.j.issn.0253-2727.2019.06.016. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31340630 Free PMC article. Chinese. No abstract available.

7

Ruxolitinib combined with dexamethasone in adult patients with newly diagnosed Hemophagocytic lymphohistiocytosis: A single-center pilot trial.

Zhou D, Huang X, Xie M, Zhu L, Huang X, Li X, Yang X, Li L, Zhu J, Zheng X, Sun J, Zhao S, Yu W, Xie W, Tong H, Jin J, Zhu H, Ye X. Zhou D, et al. Among authors: li x, li l. Am J Hematol. 2023 May;98(5):E106-E109. doi: 10.1002/ajh.26877. Epub 2023 Feb 22. Am J Hematol. 2023. PMID: 36789563 Free article. No abstract available.

8

A novel angiogenesis-related scoring model predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma.

Liu Y, Wang J, Shen X, Li L, Zhang N, Wang X, Tang B. Liu Y, et al. Among authors: li l. Clin Exp Med. 2023 Nov;23(7):3781-3797. doi: 10.1007/s10238-023-01127-9. Epub 2023 Jul 4. Clin Exp Med. 2023. PMID: 37402040

9

The short isoform of the long-type PML-RARA fusion gene in acute promyelocytic leukaemia lacks sensitivity to all-trans-retinoic acid.

Tan Y, Bian S, Xu Z, Chen X, Qi X, Ren F, Li L, Guo H, Xu A, Zhang L, Wang H. Tan Y, et al. Among authors: li l. Br J Haematol. 2013 Jul;162(1):93-7. doi: 10.1111/bjh.12362. Epub 2013 Apr 30. Br J Haematol. 2013. PMID: 23627671 Free article.

10

Combing oncolytic adenovirus expressing Beclin-1 with chemotherapy agent doxorubicin synergistically enhances cytotoxicity in human CML cells in vitro.

Li L, You LS, Mao LP, Jin SH, Chen XH, Qian WB. Li L, et al. Acta Pharmacol Sin. 2018 Feb;39(2):251-260. doi: 10.1038/aps.2017.100. Epub 2017 Sep 14. Acta Pharmacol Sin. 2018. PMID: 28905936 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92,388 results

Search Page